** Shares of pharmaceuticals products manufacturer Consun
Pharmaceutical Group Ltd 1681.HK fall 9.9 percent to HK$8.63,
their lowest since May 7
** Shareholder Far East Horizon sells its entire 9.2 percent
stake in Consun Pharmaceutical, at a price representing over 10
percent discount to the previous close, for $88 million,
according to a report from Reuters' publication IFR urn:newsml:reuters.com:*:nL3N1T21C6
** As of 0159 GMT, about 89.86 million shares of the
Guangdong-based company have been traded, compared with their
30-day moving average of 1.63 million shares a day
** Among the three analysts that cover Consun
Pharmaceutical, the current average rating on the shares is
"buy"; the breakdown of recommendations is three "strong buy" or
"buy". The analyst mean price target is HK$10.28 - Thomson
Reuters Eikon data
** Hong Kong benchmark index .HSI rises 0.5 pct
(RM: donny.kwok.thomsonreuters.com@reuters.net)